Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. diplomat pharmacy inc.
483
•diplomat pharmacy inc. •November 17, 2017

diplomat pharmacy inc. – FDA 483, Nov 17, 2017

Record Details

During an inspection from October 31 to November 17, 2017, the FDA issued a Form 483 to Diplomat Pharmacy Inc. dba Diplomat Specialty Pharmacy, a producer of sterile and non-sterile drug products in Flint, Michigan. The observations highlighted several significant deviations from regulatory standards, primarily concerning good manufacturing practices and sterile product control. Key issues included critical cleanliness failures within the ISO 5 classified aseptic processing areas, where inspectors observed rust-colored residues and discolorations on laminar flow hoods and HEPA filter screens, indicating inadequate cleaning and potential contamination risks. Furthermore, a HEPA filter patch exceeding specified size limits compromised the sterile air quality in a processing hood, where sterile drug products like Enoxaparin and Neupogen were routinely prepared. The company also used non-sterile cleaning wipes in these critical sterile processing environments, even when used with sterile disinfectants, which directly jeopardized product sterility. A serious quality control violation involved the release of Dexamethasone 40 MG and 10 MG capsules that initially showed out-of-specification potency results (153% and 143% respectively). Although subsequent re-tests were within limits, affected lots were dispensed to patients prior to the receipt of these OOS results, demonstrating a failure in product release protocols. These observations indicate a need for immediate corrective actions to ensure compliance with Current Good Manufacturing Practices, particularly in maintaining aseptic conditions and robust quality control for drug product release, to protect patient safety.

Company
diplomat pharmacy inc.
Inspection date
November 17, 2017
Product type
Drugs
Office
Detroit District Office
Person
  • Emily J. Orban
View Company Profile

ID · 47f0ea77-c092-4bcd-a064-bfc9c0b94cc0

Violation Codes3
21 CFR 21021 CFR 21121 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for diplomat pharmacy inc.
  • STATE_REFERRAL_LETTER - 2017-10-31October 31, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore diplomat pharmacy inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.